Current Therapeutic Strategy for Multiple Myeloma

ISSN： 1465-3621

Source： Japanese Journal of Clinical Oncology, Vol.43, Iss.2, 2013-02, pp. : 116-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutic targets for multiple myeloma

By Mahindra Anuj Cirstea Diana Raje Noopur

Future Oncology, Vol. 6, Iss. 3, 2010-03 ,pp. : 407-418

Future Medicine

Access to resources Recommend Favorite

Bortezomib: A valuable new antineoplastic strategy in multiple myeloma

By Bladé Joan Cibeira M. Teresa Rosiñol Laura

Acta Oncologica, Vol. 44, Iss. 5, 2005-07 ,pp. : 440-448

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Multiple Myeloma: Current Management and New Approaches

By Ho P.J. Gibson J. Joshua D.E.

American Journal of Cancer, Vol. 3, Iss. 1, 2004-01 ,pp. : 47-66

Adis International

Access to resources Recommend Favorite

PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma

By Harvey R Donald Lonial Sagar

Future Oncology, Vol. 3, Iss. 6, 2007-12 ,pp. : 639-647

Future Medicine

Access to resources Recommend Favorite

Therapeutic effects of autologous hematopoietic stem cell transplantation in multiple myeloma patients

Experimental and Therapeutic Medicine, Vol. 6, Iss. 4, 2013-01 ,pp. : 977-982

Spandidos Publications

Access to resources Recommend Favorite